NCT Heidelberg

Scientific Advisory Board

The Scientific Advisory Board at the NCT provides strategic support to the NCT in all material respects. The Advisory Board advises the cross-regional steering committee and the NCT Directors in Heidelberg and Dresden in all scientific and clinical matters as well as conceptional questions. It consists of renowned clinicians and scientists from national and international clinical/scientific and purely scientifically oriented institutions.

Members of the Scientific Advisory Board

Prof. Raymond DuBois (Chairman)
The Biodesign Institute Arizona University, USA

Prof. Robert Bristow
Manchester Cancer Research Centre, The University of Manchester, UK

Prof. David Gonzalez de Castro

Queen’s University, Belfast, UK

Prof. Ruggero de Maria
Alleanza Contro il Cancro (ACC), Italy

Prof. Alexander Eggermont
Institute de Cancérologie Gustave Roussy, France

Prof. Michelle Le Beau
The University of Chicago Comprehensive Cancer Center (UCCCC), The University of Chicago, USA

Prof. Claudia Lengerke
Departement of Biomedicine, University Hospital Basel, Switzerland

Prof. Elaine Mardis
McDonnell Genome Institute, Washington University in St. Louis, USA

Prof. Cornelis J.M. Melief

Leiden University Medical Center, Netherlands

Prof. Radhe Mohan
UT MD Anderson Cancer Center, USA

Prof. Michael Molls
Technische Universität München, Germany

Prof. Ulrik Ringborg

Cancer Center Karolinska, Karolinska University Hospital, Sweden

Prof. Yardena Samuels
Department of Moleular Cell Biology, The Weizmann Institute of Science, Israel

Prof. Tom Sellers
H. Lee Moffitt Cancer Center &  Research Institute, USA

Prof. Paresh Vyas
Oxford University Hospital, UK